Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Insulet Corp (PODD)

Insulet Corp (PODD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stocks Settled Mixed as Higher Bond Yields Weigh on Sentiment

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.91%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.89%. September E-mini...

AVGO : 283.34 (-1.09%)
TTD : 80.21 (-1.51%)
LVS : 48.67 (-0.53%)
WYNN : 106.77 (-2.44%)
$IUXX : 23,065.47 (-0.05%)
ASML : 734.58 (-1.39%)
ZNU25 : 110-250s (+0.24%)
R : 169.90 (-1.22%)
TSLA : 329.65 (+3.21%)
ESU25 : 6,334.75s (-0.09%)
SG : 14.31 (+5.30%)
AMD : 156.99 (-2.13%)
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential

BEAM : 20.75 (+1.47%)
INSP : 126.83 (-0.89%)
LFMD : 10.55 (-4.95%)
KRYS : 147.49 (-1.77%)
OPCH : 29.48 (-1.54%)
VEEV : 282.29 (+2.11%)
TMDX : 109.88 (-2.35%)
PODD : 284.23 (+0.28%)
CERT : 10.10 (-4.17%)
TEM : 60.98 (+0.54%)
How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?

Insulet has outperformed the Medical Devices industry over the past year, and analysts are highly optimistic about the stock’s prospects.

PODD : 284.23 (+0.28%)
IHI : 60.06 (+0.15%)
DXCM : 83.89 (-0.25%)
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TNDM),(NYSE:NVO),(NASDAQ:PODD),(NYSE:MDT) EQNX::TICKER_END

AVAI : 0.6100 (+1.67%)
TNDM : 14.77 (-3.84%)
NVO : 64.31 (-1.50%)
PODD : 284.23 (+0.28%)
MDT : 89.61 (+0.09%)
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities

AVAI : 0.6100 (+1.67%)
TNDM : 14.77 (-3.84%)
NVO : 64.31 (-1.50%)
PODD : 284.23 (+0.28%)
MDT : 89.61 (+0.09%)
DexCom Stock: Is DXCM Underperforming the Health Care Sector?

DexCom has underperformed the Health Care sector over the past year, but analysts are highly optimistic about the stock’s prospects.

XLV : 131.84 (-0.66%)
PODD : 284.23 (+0.28%)
DXCM : 83.89 (-0.25%)
3 Medical Technology Stocks Outperforming in 2025

Three med-tech stocks, TransMedics, Insulet, and GRAIL, are outperforming the market and their sector while forming bullish technical patterns.

GRAL : 35.19 (-2.03%)
TMDX : 109.88 (-2.35%)
PODD : 284.23 (+0.28%)
Do Wall Street Analysts Like Insulet Stock?

Insulet has significantly outpaced the broader market over the past year, and analysts remain bullish on the stock’s prospects.

C : 93.45 (+0.39%)
$SPX : 6,296.79 (-0.01%)
PODD : 284.23 (+0.28%)
IHI : 60.06 (+0.15%)
Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer

Insulet's earnings and upgraded guidance recently propelled its stock to S&P 500 leadership, showcasing strong execution in the diabetes care market.

PODD : 284.23 (+0.28%)
Dow leaps 1,100 points and S&P 500 rallies 3.3% following a 90-day truce in the US-China trade war

U.S. stocks rallied after China and the United States announced a 90-day truce in their trade war

NVDA : 172.41 (-0.34%)
NRG : 151.75 (+2.97%)
AVGO : 283.34 (-1.09%)
BMO.TO : 156.85 (-0.22%)
$SPX : 6,296.79 (-0.01%)
JNJ : 163.70 (+0.44%)
EXPE : 184.93 (+1.57%)
ABNB : 139.34 (+0.03%)
$IUXX : 23,065.47 (-0.05%)
PFE : 24.47 (-0.45%)
DAL : 56.29 (-0.09%)
SG : 14.31 (+5.30%)

Barchart Exclusives

The Saturday Spread: Using Science to Pinpoint Empirically Enticing Trades in WMT, OKTA and RCAT
If you’re going to extract alpha from the market, you’ll need an objective framework to benchmark and quantify your performance. This article will show you how. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar